Skip to content

Clinical epidemiology of Long Covid/Post-Covid-Syndrom - a validation study

Clinical epidemiology of Long Covid/Post-Covid-Syndrom - a validation study - EPILOC Phase 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00027362
Enrollment
1600
Registered
2024-05-14
Start date
2021-12-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9

Interventions

Group 1: Questionnaire study and clinical examination of adult subjects with and without Post-Covid syndrome after SARS-CoV-2 infection at least 12 months before

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Previous participation in EPILOC Phase 1 and willingnesse (consent in writing) to participate in EPILOC Phase 2 and use information from EPILOC Phase 1 - Presence of Post-Covid syndrome or freedom of symptoms during EPILOC Phase 1

Exclusion criteria

Exclusion criteria: - Inability to attend the outpatient medical examination

Design outcomes

Primary

MeasureTime frame
Cardiorespiratory or cognitive functional deficits in subjects with persistent Post-Covid syndrome at least 12 months after acute infection

Secondary

MeasureTime frame
- clinically relevant abnormal laboratory values - frequency of exertional intolerance (expressed as PEM >14 h) - frequency of genetic variants associated with persistent Post-Covid syndrome - symptomatic improvement in comparison with information provided in Phase 1

Countries

Germany

Contacts

Public ContactWinfried V. Kern

Universitätsklinikum Freiburg

winfried.kern@uniklinik-freiburg.de+4976127018190

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026